v3.25.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
Retained Earnings [Member]
Total
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 79,114 22,430        
Total equity, beginning of period at Dec. 31, 2021 $ 79 $ 22 $ 553,787 $ (6,772) $ 1,194,272 $ 1,741,388
Stock-based compensation     33,466     33,466
Grant of contingent restricted stock units     1,985     1,985
Exercise of stock options $ 1   41,714     41,715
Exercise of stock options (shares) 999          
Comprehensive income/(loss)       (17,858) 190,169 172,311
Repurchase and retirement of common stock $ (2)       (144,491) (144,493)
Repurchase and retirement of common stock (shares) (2,351)          
Total equity, end of period at Dec. 31, 2022 $ 78 $ 22 630,952 (24,630) 1,239,951 1,846,373
Shares, Outstanding, Ending Balance at Dec. 31, 2022 77,762 22,430        
Stock-based compensation     52,773     52,773
Grant of contingent restricted stock units     1,925     1,925
Exercise of stock options (shares) 387          
Exercise of stock options     12,396     12,396
Issuance of Class A common stock under employee and director equity option plans, net     (11,409)     (11,409)
Issuance of Class A common stock under employee and director equity option plans, net (shares) 273          
Issuance of Class A equity for NuVasive Merger $ 40   2,184,112     2,184,152
Issuance of Class A equity for NuVasive Merger (shares) 39,813          
Comprehensive income/(loss)       14,438 122,873 137,311
Repurchase and retirement of common stock $ (4)       (225,558) (225,562)
Repurchase and retirement of common stock (shares) (4,329)          
Total equity, end of period at Dec. 31, 2023 $ 114 $ 22 2,870,749 (10,192) 1,137,266 3,997,959
Shares, Outstanding, Ending Balance at Dec. 31, 2023 113,906 22,430        
Stock-based compensation     54,287     54,287
Grant of contingent restricted stock units     2,500     2,500
Exercise of stock options $ 3   110,437     $ 110,440
Exercise of stock options (shares) 2,450         2,450
Issuance of Class A common stock under employee and director equity option plans, net     (6,729)     $ (6,729)
Issuance of Class A common stock under employee and director equity option plans, net (shares) 261          
Comprehensive income/(loss)       3,331 102,984 106,315
Repurchase and retirement of common stock $ (2)       (87,437) (87,439)
Repurchase and retirement of common stock (shares) (1,627)          
Total equity, end of period at Dec. 31, 2024 $ 115 $ 22 $ 3,031,244 $ (6,861) $ 1,152,813 $ 4,177,333
Shares, Outstanding, Ending Balance at Dec. 31, 2024 114,990 22,430